相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, against Clostridium difficile
Tarun Mathur et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Ten-year review of Clostridium difficile infection in acute care hospitals in the USA, 2005-2014
R. Luo et al.
JOURNAL OF HOSPITAL INFECTION (2018)
Antibiotic Stewardship Programs in Nursing Homes: A Systematic Review
Diana Feldstein et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2018)
Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections
Jae Hyun Shin et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2016)
Clostridium difficile Infection
Daniel A. Leffler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Burden of Clostridium difficile Infection in the United States
Fernanda C. Lessa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Persistent and Recurrent Clostridium difficile Colitis
Shola A. Cole et al.
CLINICS IN COLON AND RECTAL SURGERY (2015)
Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection
Simon D. Baines et al.
ANTIBIOTICS-BASEL (2015)
Is Fidaxomicin Worth the Cost? An Economic Analysis
Sarah M. Bartsch et al.
CLINICAL INFECTIOUS DISEASES (2013)
Epidemiology of Community-Associated Clostridium difficile Infection, 2009 Through 2011
Amit S. Chitnis et al.
JAMA INTERNAL MEDICINE (2013)
Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
Thomas J. Louie et al.
CLINICAL INFECTIOUS DISEASES (2012)
Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence
Konstantinos Z. Vardakas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
Biology of Clostridium difficile: Implications for Epidemiology and Diagnosis
Karen C. Carroll et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 65 (2011)
Relapse Versus Reinfection: Surveillance of Clostridium difficile Infection
Mini Kamboj et al.
CLINICAL INFECTIOUS DISEASES (2011)
Enterotypes of the human gut microbiome
Manimozhiyan Arumugam et al.
NATURE (2011)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Recurrent Clostridium difficile infection: causality and therapeutic approaches
Stuart Johnson
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Monitoring Bacterial Community of Human Gut Microbiota Reveals an Increase in Lactobacillus in Obese Patients and Methanogens in Anorexic Patients
Fabrice Armougom et al.
PLOS ONE (2009)
Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea
Ju Young Chang et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Breaking the cycle:: Treatment strategies for 163 cases of recurrent Clostridium difficile disease
LV McFarland et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
Confidence interval criteria for assessment of dose proportionality
BP Smith et al.
PHARMACEUTICAL RESEARCH (2000)
分享论文
